Effect of CYP1A1 polymorphism on the clinical efficacy of docetaxel combined with capecitabine in the treatment of metastatic breast cancer

Lin Li; Youyi Xiong; Fang Wang; Guangcheng Guo; Wei Qin; Mingzhi Zhu; Nan Wang; Xin Duan; Zhuo Chen; Hailong Mi

doi:10.3760/cma.j.issn.1001-9030.2017.10.043

Effect of CYP1A1 polymorphism on the clinical efficacy of docetaxel combined with capecitabine in the treatment of metastatic breast cancer

Identifier:nobleid.org/w1/20260515/B2ABF9DC

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

View Original Paper Source

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/B2ABF9DC.svg?ark=w1%2F20260515%2FB2ABF9DC)](https://nobleid.org/work/w1/20260515/B2ABF9DC)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Claim authorship of this work

Effect of CYP1A1 polymorphism on the clinical efficacy of docetaxel combined with capecitabine in the treatment of metastatic breast cancer

Identifier:nobleid.org/w1/20260515/B2ABF9DC

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

View Original Paper Source

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/B2ABF9DC.svg?ark=w1%2F20260515%2FB2ABF9DC)](https://nobleid.org/work/w1/20260515/B2ABF9DC)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Claim authorship of this work